Patents by Inventor Paul L. Kornblith

Paul L. Kornblith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8183009
    Abstract: An improved system for assaying expression of various markers, factors or antigens on the cultured cells for diagnostic purposes and for using such expression to monitor the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: May 22, 2012
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Publication number: 20120088264
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined.
    Type: Application
    Filed: October 6, 2011
    Publication date: April 12, 2012
    Applicant: Precision Therapeutics, Inc.
    Inventor: Paul L. KORNBLITH
  • Patent number: 8058025
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 15, 2011
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Patent number: 8039213
    Abstract: Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: October 18, 2011
    Assignee: Precision Therapeutics, Inc.
    Inventors: Paul L. Kornblith, Sean McDonald
  • Patent number: 7972769
    Abstract: An improved method for preparing a cell culture is disclosed. The method includes culturing a multicellular tissue explant in the presence of growth medium that is substantially free of enzymes capable of digesting the explant and, subsequently, removing the explant at a predetermined time.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: July 5, 2011
    Assignee: Precision Therapeutics, Inc.
    Inventors: Paul L. Kornblith, Sheri Gimigliano
  • Publication number: 20110020826
    Abstract: Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
    Type: Application
    Filed: October 5, 2010
    Publication date: January 27, 2011
    Applicant: Precision Therapeutics, Inc.
    Inventors: Paul L. Kornblith, Sean McDonald
  • Publication number: 20100330613
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined.
    Type: Application
    Filed: July 1, 2010
    Publication date: December 30, 2010
    Applicant: Precision Therapeutics, Inc.
    Inventor: Paul L. KORNBLITH
  • Patent number: 7829288
    Abstract: Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: November 9, 2010
    Assignee: Precision Therapeutics, Inc.
    Inventors: Paul L. Kornblith, Sean McDonald
  • Patent number: 7771963
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: August 10, 2010
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Publication number: 20100120070
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
    Type: Application
    Filed: January 20, 2010
    Publication date: May 13, 2010
    Inventor: Paul L. KORNBLITH
  • Patent number: 7678552
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: March 16, 2010
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Publication number: 20090286255
    Abstract: Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
    Type: Application
    Filed: July 28, 2009
    Publication date: November 19, 2009
    Inventors: Paul L. Kornblith, Sean McDonald
  • Patent number: 7575868
    Abstract: Methods are provided for accurately predicting efficacy of chemotherapeutic agents. Methods of the invention increase the positive predictive value of chemosensitivity assays by assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. Results obtained using methods of the invention provide insight into the in vivo effectiveness of a therapeutic, and lead to more effective chemotherapeutic treatment.
    Type: Grant
    Filed: March 5, 2007
    Date of Patent: August 18, 2009
    Assignee: Precision Therapeutics, Inc.
    Inventors: Paul L. Kornblith, Sean McDonald
  • Patent number: 7563593
    Abstract: The present invention provides an improved system for determining factors secreted from patient cells, in which a tissue sample from the patient is harvested and cultured. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. The tissue sample technique of the present invention is also-useful in assaying expression and/or secretion of various markers, factors or antigens present on or produced by the cultured cells for diagnostic purposes and for using such expression to monitor the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: July 21, 2009
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Patent number: 7501260
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample, rather than enzymatically dissociated cell suspensions or preparations, for initial tissue culture monolayer preparation.
    Type: Grant
    Filed: November 26, 2007
    Date of Patent: March 10, 2009
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Publication number: 20090042221
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. Specific method innovations such as tissue sample preparation techniques render this method practically as well as theoretically useful. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample, rather than enzymatically dissociated cell suspensions or preparations, for initial tissue culture monolayer preparation.
    Type: Application
    Filed: October 2, 2008
    Publication date: February 12, 2009
    Inventor: Paul L. KORNBLITH
  • Publication number: 20090042225
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
    Type: Application
    Filed: September 10, 2008
    Publication date: February 12, 2009
    Inventor: Paul L. KORNBLITH
  • Patent number: 7314731
    Abstract: The present invention discloses in vitro methods for screening candidate therapeutic and/or chemotherapeutic agents for in vivo efficacy in a specific patient. The invention also includes methods for determining the optimal dosage of a therapeutic agent for a specific patient. The methods include the use of cohesive multicellular particulates of tissue, rather than enzymatically dissociated cell suspensions or preparations, to prepare tissue culture monolayers representative of in vivo cell populations.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: January 1, 2008
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Patent number: 7112415
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: September 26, 2006
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith
  • Patent number: 6933129
    Abstract: An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.
    Type: Grant
    Filed: March 16, 1998
    Date of Patent: August 23, 2005
    Assignee: Precision Therapeutics, Inc.
    Inventor: Paul L. Kornblith